Search Results - Qundan Wu
- Showing 1 - 1 results of 1
-
1
Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 as the first-line treatment for CLDN18.2-positive, HER2-negative advanced gastric or Gastroesophageal Adenocarcinoma by Yufan Huang, Maojin You, Qundan Wu, Ruijia Chen
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book